 Sympathomimetics acute severe asthma agonists Sympathomimetics mainstay treatment acute asthma Aerosolization sympathomimetics great bronchodilation acute severe asthma systemic effects parenteral therapy broncho-selectivity route administration cardiostimulation major dose-limiting factor safe use sustained high-dose therapy agents article pharmacology adverse effects toxicities beta agonists clinical studies question title ideal study question authors available evidence preferential use selective beta agonists patients acute severe asthma high doses beta agonists